113 related articles for article (PubMed ID: 9806485)
1. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.
Zembower DE; Lin YM; Flavin MT; Chen FC; Korba BE
Antiviral Res; 1998 Aug; 39(2):81-8. PubMed ID: 9806485
[TBL] [Abstract][Full Text] [Related]
2. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
Korba BE; Boyd MR
Antimicrob Agents Chemother; 1996 May; 40(5):1282-4. PubMed ID: 8723485
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activities of biflavonoids.
Lin YM; Flavin MT; Schure R; Chen FC; Sidwell R; Barnard DL; Huffman JH; Kern ER
Planta Med; 1999 Mar; 65(2):120-5. PubMed ID: 10193201
[TBL] [Abstract][Full Text] [Related]
4. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
[TBL] [Abstract][Full Text] [Related]
5. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
Fu L; Cheng YC
Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
[TBL] [Abstract][Full Text] [Related]
6. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of combination therapies against hepatitis B virus replication.
Korba BE
Antiviral Res; 1996 Jan; 29(1):49-51. PubMed ID: 8721544
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
Lomonosova E; Zlotnick A; Tavis JE
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956427
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-HBV activity of beta-D- and beta-L-DDA-5'monophosphate prodrugs and effectiveness in combination with lamivudine.
Loi AG; Faraj A; Pierra C; Gosselin G; Imbach JL; Locarnini SA; Groman EV; Schinazi RF; Sommadossi JP
Nucleosides Nucleotides; 1999; 18(4-5):1005-6. PubMed ID: 10432731
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
15. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora.
Lin YM; Anderson H; Flavin MT; Pai YH; Mata-Greenwood E; Pengsuparp T; Pezzuto JM; Schinazi RF; Hughes SH; Chen FC
J Nat Prod; 1997 Sep; 60(9):884-8. PubMed ID: 9322359
[TBL] [Abstract][Full Text] [Related]
16. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
17. Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction.
Tsukamoto Y; Ikeda S; Uwai K; Taguchi R; Chayama K; Sakaguchi T; Narita R; Yao WL; Takeuchi F; Otakaki Y; Watashi K; Wakita T; Kato H; Fujita T
PLoS One; 2018; 13(5):e0197664. PubMed ID: 29782545
[TBL] [Abstract][Full Text] [Related]
18. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
Ying C; De Clercq E; Neyts J
Antiviral Res; 2000 Nov; 48(2):117-24. PubMed ID: 11114413
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.
Semaine W; Johar M; Tyrrell DL; Kumar R; Agrawal B
J Med Chem; 2006 Mar; 49(6):2049-54. PubMed ID: 16539393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
